Bioorganic and Medicinal Chemistry Letters p. 4285 - 4288 (2003)
Update date:2022-08-04
Topics:
Perkins, James J.
Duong
Fernandez-Metzler, Carmen
Hartman, George D.
Kimmel, Donald B.
Leu, Chih-Tai
Lynch, Joseph J.
Prueksaritanont, Thomayant
Rodan, Gideon A.
Rodan, Sevgi B.
Duggan, Mark E.
Meissner, Robert S.
Antagonists of the integrin receptor αvβ3 are expected to have utility in the treatment of osteoporosis through inhibition of bone resorption. A series of potent, chain-shortened, pyrrolidinone-containing αvβ3 receptor antagonists is described. Two sets of diasteromeric pairs of high-affinity antagonists demonstrated marked differences in log P values, which translated into differing dog pharmacokinetic properties. One member of this set was demonstrated to be effective in reducing bone resorption in rats.
View MoreQingdao Kylin Trading Co., Ltd.
Contact:0086-532-68979884/58972912/68972263/65/88171519
Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Contact:86-931-8272767
Address:Room 602, No.461, Nanchang Road, Chengguan District, Lanzhou City, China PRC
Shao Xing Empire Import&Export CO.,ltd
Contact:86-575-82127757
Address:11#, Weiwu Road, Shangyu Industrial Park, Hangzhou Bay, Hangzhou, Zhejiang Province, China
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Doi:10.1021/ja01860a014
(1940)Doi:10.1016/S0040-4039(99)00577-8
(1999)Doi:10.1016/S0968-0896(02)00606-5
(2003)Doi:10.1039/j39690001346
(1969)Doi:10.1016/S0040-4020(99)00307-5
(1999)Doi:10.1016/S0031-9422(00)91376-1
(1974)